Tag Archives: Gut microbes
Are probiotic treatments useful on FM or CFS patients?
Review abstract: Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review, by P. Roman, F. Carrillo-Trabalón, N. Sánchez-Labraca, AF Estévez, D. Cardona in Benef Microbes. 2018 Apr 26:1-10 [Epub ahead of print] Evidence suggests … Continue reading
Could gut dysfunction in Parkinson’s overlap with ME?
ME global chronicle article, October 2016: Parkinson’s disease protection may begin in the gut. Why an article on Parkinson’s in an ME-magazine, one might ask. There seems to be more and more suspicion that there’s overlap between Parkinson’s, Alzheimer’s and ALS with ME. The findings … Continue reading
Gut bacteria play different roles in males & females with CFS
Article in AJP blog: Gut bacteria play different roles in males and females, by Megan Haggan, 29 January 2016 Gut bacteria play vastly different roles in males and females even when the microbe balance of the gut looks exactly the … Continue reading
Could toll-like receptors be a new therapeutic approach for ME?
Article abstract Perturbations in immune processes play an important role in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), a multifactorial disorder mainly characterized by severe and prolonged fatigue and typically affecting a variety of bodily systems including the immune system. Recent reports … Continue reading
Microbial Diagnostics and Discovery in ME/CFS – transcript of Lipkin talk
Transcript of Ian Lipkin MD’s talk at the Stanford ME/CFS Symposium in March, prepared by Patricia Carter of ME/CFS Forums is online: Microbial Diagnostics and Discovery in ME/CFS Dr. Ian Lipkin. is the John Snow Professor of Epidemiology and Professor … Continue reading
Probiotic can reduce pro-inflammatory cytokines in ME/CFS
Research abstract Certain therapeutic microbes, including Bifidobacteria infantis (B. infantis) 35624 exert beneficial immunoregulatory effects by mimicking commensal-immune interactions; however, the value of these effects in patients with non-gastrointestinal inflammatory conditions remains unclear. Method: In this study, we assessed the … Continue reading
